{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:50:57Z","timestamp":1767966657461,"version":"3.49.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.cct.2023.107334","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T11:58:46Z","timestamp":1695038326000},"page":"107334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trial"],"prefix":"10.1016","volume":"133","author":[{"given":"Kate","family":"Wolitzky-Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa J.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Metts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Marie","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Hanano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben","family":"Ram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cct.2023.107334_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/BRS.0b013e3181657e0d","article-title":"Effects of two guideline implementation strategies on patient outcomes in primary care: a cluster randomized controlled trial","volume":"33","author":"Becker","year":"2008","journal-title":"Spine"},{"issue":"8","key":"10.1016\/j.cct.2023.107334_bb0010","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1176\/ajp.152.8.1156","article-title":"Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder","volume":"152","author":"Bruce","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1037\/0022-006X.67.1.151","article-title":"Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following alprazolam discontinuation: a long-term follow-up of the Peoria and Dartmouth studies","volume":"67","author":"Bruce","year":"1999","journal-title":"J. Consult. Clin. Psychol."},{"issue":"3","key":"10.1016\/j.cct.2023.107334_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2012.11.018","article-title":"National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999\u20132009","volume":"131","author":"Calcaterra","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20133","key":"10.1016\/j.cct.2023.107334_bb0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jad.2008.03.014","article-title":"Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS)","volume":"112","author":"Campbell-Sills","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.cct.2023.107334_bb0030","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11606-019-05545-y","article-title":"Risk of overdose with exposure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study","volume":"35","author":"Cho","year":"2020","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.cct.2023.107334_bb0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"64","author":"Compton","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2023.107334_bb0040","series-title":"Yale adherence and competence scale guidelines","author":"Corvino","year":"2000"},{"issue":"3","key":"10.1016\/j.cct.2023.107334_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0887-6185(94)90001-9","article-title":"Patient satisfaction with behavioral treatments for panic disorder with agoraphobia","volume":"8","author":"Cox","year":"1994","journal-title":"J. Anxiety Disord."},{"issue":"5","key":"10.1016\/j.cct.2023.107334_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.annemergmed.2019.04.019","article-title":"Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis","volume":"74","author":"Cragg","year":"2019","journal-title":"Ann. Emerg. Med."},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jclp.10255","article-title":"Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings","volume":"60","author":"Deacon","year":"2004","journal-title":"J. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.cct.2023.107334_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","article-title":"Psychometric properties of the credibility\/expectancy questionnaire","volume":"31","author":"Devilly","year":"2000","journal-title":"J. Behav. Ther. Exp. Psychiatry"},{"issue":"Supplement 1","key":"10.1016\/j.cct.2023.107334_bb0065","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.3122\/jabfm.2015.S1.150112","article-title":"Strategies to support the integration of behavioral health and primary care: what have we learned thus far?","volume":"28","author":"Dickinson","year":"2015","journal-title":"J. Am. Board Family Med."},{"key":"10.1016\/j.cct.2023.107334_bb0070","author":"Dietary Guidelines Advisory Committee"},{"issue":"9","key":"10.1016\/j.cct.2023.107334_bb0075","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jpain.2011.02.357","article-title":"Elevated pain sensitivity in chronic pain patients at risk for opioid misuse","volume":"12","author":"Edwards","year":"2011","journal-title":"J. Pain"},{"key":"10.1016\/j.cct.2023.107334_bb0080","series-title":"Using Computers in Qualitative Research","author":"Fielding","year":"1991"},{"key":"10.1016\/j.cct.2023.107334_bb0085","series-title":"SCID-5-CV: Structured Clinical Interview for DSM-5 Disorders: Clinician Version","author":"First","year":"2016"},{"issue":"3","key":"10.1016\/j.cct.2023.107334_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.cct.2023.107334_bb0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s11606-007-0201-9","article-title":"A randomized trial of telemedicine-based collaborative care for depression","volume":"22","author":"Fortney","year":"2007","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.cct.2023.107334_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1258\/135763307780677604","article-title":"A randomized trial of telepsychiatry for post-traumatic stress disorder","volume":"13","author":"Frueh","year":"2007","journal-title":"J. Telemed. Telecare"},{"issue":"7","key":"10.1016\/j.cct.2023.107334_bb0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MLR.0000000000000738","article-title":"Patterns of opioid use and risk of opioid overdose death among Medicaid patients","volume":"55","author":"Garg","year":"2017","journal-title":"Med. Care"},{"issue":"8","key":"10.1016\/j.cct.2023.107334_bb0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2023.107334_bb0115","series-title":"The Discovery of Grounded Theory: Strategies for Qualitative Research","author":"Glaser","year":"1967"},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/2150131916656455","article-title":"Overcoming barriers to integrating behavioral health and primary care services","volume":"7","author":"Grazier","year":"2016","journal-title":"J. Prim. Care Community Health"},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0125","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12689","article-title":"New coprescription of opioids and benzodiazepines and mortality among veteran affairs patients with posttraumatic stress disorder","volume":"80","author":"Hawkins","year":"2019","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00952990.2010.535581","article-title":"Anxiety sensitivity and illicit sedative use among opiate-dependent women and men","volume":"37","author":"Hearon","year":"2011","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.cct.2023.107334_bb0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/nur.20247","article-title":"Considerations in determining sample size for pilot studies","volume":"31","author":"Herzog","year":"2008","journal-title":"Res. Nurs. Health"},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.cct.2023.107334_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/PSY.0b013e3181e2c4a0","article-title":"Barriers to physical and mental condition integrated service delivery","volume":"72","author":"Kathol","year":"2010","journal-title":"Psychosom. Med."},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0150","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14622200801979043","article-title":"Exercise as an adjunct to nicotine gum in treating tobacco dependence among women","volume":"10","author":"Kinnunen","year":"2008","journal-title":"Nicotine Tob. Res."},{"issue":"6","key":"10.1016\/j.cct.2023.107334_bb0155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-009-0981-1","article-title":"Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference","volume":"24","author":"Krebs","year":"2009","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.cct.2023.107334_bb0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","article-title":"Design and analysis of pilot studies: recommendations for good practice","volume":"10","author":"Lancaster","year":"2004","journal-title":"J. Eval. Clin. Pract."},{"issue":"6","key":"10.1016\/j.cct.2023.107334_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20180521-03","article-title":"Benzodiazepine use: the underbelly of the opioid epidemic","volume":"56","author":"Limandri","year":"2018","journal-title":"J. Psychosoc. Nurs. Mental Health"},{"key":"10.1016\/j.cct.2023.107334_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2019.03.007","article-title":"Telemedicine-delivered treatment interventions for substance use disorders: a systematic review","volume":"101","author":"Lin","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2023.107334_bb0175","series-title":"Manual for the Depression Anxiety Stress Scales (DASS)","author":"Lovibond","year":"1993"},{"key":"10.1016\/j.cct.2023.107334_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1525822X980100020301","article-title":"Code book development for team-based qualitative analysis","volume":"10","author":"MacQueen","year":"1988","journal-title":"CAM J."},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.cct.2023.107334_bb0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.addbeh.2016.08.020","article-title":"Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder","volume":"65","author":"McHugh","year":"2017","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2013.11.010","article-title":"Exercise for methamphetamine dependence: rationale, design, and methodology","volume":"37","author":"Mooney","year":"2014","journal-title":"Contemp. Clin. Trials"},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/ADM.0000000000000828","article-title":"Association between benzodiazepine prescription, opioid use disorder, and mortality among patients in a large healthcare system","volume":"16","author":"Mooney","year":"2022","journal-title":"J. Addict. Med."},{"issue":"1\u20133","key":"10.1016\/j.cct.2023.107334_bb0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2012.06.032","article-title":"Risk for prescription opioid misuse among patients with a history of substance use disorder","volume":"127","author":"Morasco","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cct.2023.107334_bb0215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/pme.12594","article-title":"Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization","volume":"16","author":"Nielsen","year":"2015","journal-title":"Pain Med."},{"key":"10.1016\/j.cct.2023.107334_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brat.2017.07.002","article-title":"The NIH science of behavior change program: transforming the science through a focus on mechanisms of change","volume":"101","author":"Nielsen","year":"2018","journal-title":"Behav. Res. Ther."},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1381612023396726","article-title":"Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy","volume":"8","author":"Otto","year":"2002","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.cct.2023.107334_bb0230","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.brat.2010.04.002","article-title":"Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: further evaluation","volume":"48","author":"Otto","year":"2010","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.cct.2023.107334_bb0235","series-title":"Stopping Anxiety Medication","author":"Otto","year":"2009"},{"issue":"10","key":"10.1016\/j.cct.2023.107334_bb0240","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder","volume":"150","author":"Otto","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.cct.2023.107334_bb0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2023.107334_bb0255","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"Br. Med. J."},{"issue":"19","key":"10.1016\/j.cct.2023.107334_bb0260","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.2010.608","article-title":"Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial","volume":"303","author":"Roy-Byrne","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2023.107334_bb0265","author":"The Royal Australian College of General Practitioners"},{"key":"10.1016\/j.cct.2023.107334_bb0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.17730\/humo.58.3.g224147522545rln","article-title":"Measuring the typicality of text: using multiple coders for more than just reliability and validity checks","volume":"58","author":"Ryan","year":"1999","journal-title":"Hum. Organ."},{"key":"10.1016\/j.cct.2023.107334_bb0275","series-title":"Alcohol Timeline Followback users\u2019 Manual","author":"Sobell","year":"1995"},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/16506070601090457","article-title":"Anxiety sensitivity and its impact on pain experiences and conditions: a state of the art","volume":"35","author":"Stewart","year":"2006","journal-title":"Cogn. Behav. Ther."},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0285","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1037\/a0016032","article-title":"Cognitive\u2013behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies","volume":"77","author":"Stewart","year":"2009","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.cct.2023.107334_bb0290","series-title":"Basics of Qualitative Research: Grounded Theory Procedures and Techniques","author":"Strauss","year":"1990"},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0295","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","article-title":"The pain catastrophizing scale: development and validation","volume":"7","author":"Sullivan","year":"1995","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.cct.2023.107334_bb0300","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41562-018-0471-8","article-title":"Using rigorous methods to advance behaviour change science","volume":"2","author":"Sumner","year":"2018","journal-title":"Nat. Hum. Behav."},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0305","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC202201180","article-title":"Opioid use disorder","volume":"175","author":"Taylor","year":"2022","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.cct.2023.107334_bb0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1037\/1040-3590.19.2.176","article-title":"Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3","volume":"19","author":"Taylor","year":"2007","journal-title":"Psychol. Assess."},{"issue":"4","key":"10.1016\/j.cct.2023.107334_bb0315","first-page":"1079","article-title":"From establishing an evidence-based practice to implementation in real-world settings: IMPACT as a case study","volume":"28","author":"Un\u00fctzer","year":"2005","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.cct.2023.107334_bb0320","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.brat.2012.05.010","article-title":"Visceral sensitivity as a mediator of treatment outcome for irritable bowel syndrome","volume":"50","author":"Wolitzky-Taylor","year":"2012","journal-title":"Behav. Res. Ther."},{"issue":"1","key":"10.1016\/j.cct.2023.107334_bb0325","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/ccp0000276","article-title":"Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics","volume":"86","author":"Wolitzky-Taylor","year":"2018","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.cct.2023.107334_bb0330","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brat.2018.05.010","article-title":"Anxiety sensitivity and coping motives as putative mediators of outcome in an integrated treatment for comorbid anxiety and substance use disorders","volume":"107","author":"Wolitzky-Taylor","year":"2018","journal-title":"Behav. Res. Ther."},{"issue":"8","key":"10.1016\/j.cct.2023.107334_bb0335","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ps.62.8.pss6208_0900","article-title":"Five-year trajectories of long-term benzodiazepine use by adolescents: patient, provider, and medication factors","volume":"62","author":"Yeh","year":"2011","journal-title":"Psychiatr. Serv."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423002574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423002574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:01:48Z","timestamp":1761555708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714423002574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":66,"alternative-id":["S1551714423002574"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2023.107334","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmenting the efficacy of benzodiazepine taper with telehealth-delivered cognitive behavioral therapy for anxiety disorders in patients using prescription opioids: A pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2023.107334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107334"}}